Propecia Generic For Male Pattern Baldness

The drug propecia generic was originally intended for treating prostate enlargement or benign prostatic hyperplasia. When its branded name Proscar was released in the market, it was noticed that men who were suffering from androgenic alopecia were also being treated by the drug.  It was then that the manufacturer took notice and created some clinical studies and found out that Proscar, which came at 5mg, which at lowered dosage, particularly 1mg, could help fight androgenic alopecia.  Several years later, the brand Propecia, an offshoot of the drug Proscar was approved by the Food and Drug Administration as a treatment for androgenic alopecia.

Who is propecia generic intended for?

Propecia generic is meant for men suffering from male pattern baldness and want to stop the progression of their hair loss.  Signs of male pattern baldness would be the thinning of hair on the front, the receding of hairline on the temples, and the formation of a bald spot on the crown.  In due time, this type of baldness will let you end up bald from top to front with a rim of hair at the sides and back.  propecia generic is effective against this type of hair loss because it is able to treat it at the root of the cause – the formation of the hormone dihydrotestosterone (DHT).  Basically, this hair loss treatment prevents your hair loss from getting any worse.  If your hair loss is due to androgenic alopecia, then this is the medication for you.  Consult your doctor to know what type of hair loss you are having. Read more…

Stroke causes ranked


My mother suffered from transient ischemic storke (TIA). She was able to cover it up from her family and her GP for years. She lived alone and we only discovered her affliction after we hired a person to come in once a day to do the housekeeping and prepare her lunch. One day the helper called, frantic, to say that my mother was slumped over unconscious at the breakfast table. She came a round within a few minutes but clearly something was very wrong. I rushed over and mother confessed that she’d been having such episodes “for a few years.” Three weeks later she suffered a major stoke and went into a coma a couple of days later. She died in hospital two months after that.

Stoke continues to be a major killer of Canadians and it is on the rise. Together with heart disease, stroke accounts for on third of all deaths in Canada yet it receives scant public attention attention compared to other diseases such as breast and prostate cancer. Any responsible physician who suspects a patient is sucepible to stroke owes it to the patient to warn of the signs what actions should be taken.

A new study sheds yet more light on the causes of stroke. Hypertention continues to be the number one cause of ischaemic and intracerebral haemorrhagic stroke according to a Canadian study published in The Lancet last Friday, June 18, 2010. Of greater interest, the three year study, of 3000 patients and 3000 controls in 22 countries listed the chief causes which accounted for 90% of strokes. The participants were taken from middle and lower income groups. Contributing factors in order of their importance were:

hypertension

waist-to-hip ratio

diet risk score

diabetes mellitus

alcohol intake for more than 30 drinks per month or binge drinking;

psychosocial stress

depression

cardiac causes

Collectively, these risk factors accounted for 88·1% of stokes. When an alternate definition of hypertension was used (history of hypertension or blood pressure >160/90 mm Hg), for all stroke the percentage rose to 90.3%. The risk factors were all significant for ischaemic stroke. Hypertension, smoking, waist-to-hip ratio, diet, and alcohol intake were significant risk factors for intracerebral haemorrhagic stroke.

The conclusion, in keeping with current medical practice, suggested targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.

The study, involved 22 clinicans and was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Pfizer Cardiovascular Award, Merck, AstraZeneca, and Boehringer Ingelheim.

2 comments:

  1. sharon (aka Purley Quirt)Jun 23, 2010 07:47 AM
    This study and subsequent press release were to stimulate "the public" to take timely actions to prevent becoming a burden on the health $.

    None of this is "news" to health professionals.

    however, I am sure there is curiosity about:

    1. how the new health minister plans to implement doctors on salary and under what conditions?
    2. any discussions around the development of "health equity assessment tools" to ensure $ are going to effective programs? What's the fallout?
    3. what policies are on the table for review on followup services for patients leaving hospital?
    4. how about a new study on glycyrrhizic acid and how it can change that hip to waist ratio?
  2. hi

    well this post is good, i need all to read this post for once, thanks